Εμφανίζονται 1 - 3 Αποτελέσματα από 3 για την αναζήτηση '"ДИФФУЗНОЕ АКСОНАЛЬНОЕ ПОРАЖЕНИЕ"', χρόνος αναζήτησης: 0,52δλ Περιορισμός αποτελεσμάτων
  1. 1
    Academic Journal

    Πηγή: Neurology, Neuropsychiatry, Psychosomatics; Vol 5, No 2 (2013); 51-58 ; Неврология, нейропсихиатрия, психосоматика; Vol 5, No 2 (2013); 51-58 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2013-2

    Περιγραφή αρχείου: application/pdf

    Relation: https://nnp.ima-press.net/nnp/article/view/193/196; Laureys S., Boly M., Maquet P. Tracking the recovery of consciousness from coma. J Clin Invest 2006;7:1823-5. Laureys S., Faymonville M.E., Moonen G. et. al. PET scanning and neuronal loss in acute vegetative state. Lancet 2000;355:1825-6. Plum F., Posner J.B. The diagnosis of stupor and coma. 3rd ed. Philadelphia: F.A. Davis, 1980. Parvizi J., Damasio A. Neuroanatomical correlates of brainstem coma. Brain 2003;126:1524-36. Moore R.Y., Bloom F.E. Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Ann Rev Neurosci 1979;2:113-68. Smiley J.F., Subramanian M., Mesulam A.M. Monoaminergic-cholinergic interactions in the primate basal forebrain. Neuroscience 1999;93:817-29. Alden M., Besson J.M., Bernard J.F. Organization of the efferent projections from the pontine parabrachial area to the bed nucleus of the stria terminalis and neighboring regions: a PHA-L study in the rat. J Comp Neurol 1994;341:289-314. Krout K.E., Loewy A.D. Parabrachial nucleus projections to midline and intralaminar thalamic nuclei of the rat. J Comp Neurol 2000;428:475-94. Bester H., Bourgeais L., Villanueva L. et al. Differential projections to the intralaminar and gustatory thalamus from the parabrachial area: a PHA-L study in the rat. J Comp Neurol 1999;405:421-49. Muller C.M., Lewandowski M.H., Singer W. Structures mediating cholinergic reticular facilitation of cortical responses in the cat: effects of lesions in immunocytochemically characterized projections. Exp Brain Res 1993;96:8-18. Steriade M., Pare D., Parent A., Smith Y. Projections of cholinergic and non-cholinergic neurons of the brainstem core to relay and associational thalamic nuclei in the cat and macaque monkey. Neuroscience 1988;25:47-67. Доброхотова Т.А., Зайцев О.С. Психопатология черепно-мозговой травмы. Клиническое руководство по черепно-мозговой травме. Т.1. Под ред. А.Н. Коновалова, Л.Б. Лихтермана, А.А. Потапова. М.: АНТИДОР, 1998;269-313. Bales J.W., Kline A.E., Wagner A.K., Dixon C.E. Targeting Dopamine in Acute Traumatic Brain Injury. Open Drug Dis J 2010;2:119-28. Clauss R.P. Neurotransmitters in coma, vegetative and minimally conscious states, pharmacological interventions. Med Hypoth 2010;75(3):287—90. Voss H.U., Uluc A.M., Dyke J.P. et al. Possible axonal regrowth in late recovery from the minimally conscious state. J Clin Invest 2006;116:2005-11. Laureys S., Lemaire C., Maquet P. et al. Cerebral metabolism during vegetative state and after recovery to consciousness. J Neurol Neurosurg Psychiatry 1999;67:121-2. Cairns H., Oldfield R.C., Pennybacker J.B., Whitteridge D. Akinetic mutism with an epidermoid cyst at the third ventricle. Brain 1941;64:273-90. Park-Matsumoto Y.C., Ogawa K., Tazawa T. et al. Mutism developing after bilateral thala-mo-capsular lesions by neuro-Behcet disease. Acta Neurol Scand 1995;91:297-301. Castaigne P., Lhermitte F., Buge A. et al. Paramedian thalamic and midbrain infarct: clinical and neuropathological study. Ann Neurol 1981;10:127-48. Shetty A.C., Morris J., O'Mahony P. Akinetic mutism — not coma. Age Ageing 2009;38(3):350-1. Cavanna A.E., Bertero L., Cavanna S. et al. Persistent akinetic mutism after bilateral paramedian thalamic infarction. J Neuropsychiatry Clin Neurosci 2009;21(3):351. Freemon F.R. Akinetic mutism and bilateral anterior cerebral artery occlusion. J Neurol Neurosurg Psychiatry 1971;34:693-8. Kim M.S., Rhee J.J., Lee S.J. et al. Akinetic mutism responsive to bromocriptine following subdural hematoma evacuation in a patient with hydrocephalus. Neurol Med Chir (Tokyo) 2007;47(9):419-23. Alexander M.P. Chronic akinetic mutism after mesencephalic-diencephalic infarction: remediated with dopaminergic medications. Neurorehabil Neural Repair 2001;15(2):151-6. Kim Y.W., Shin J.C., An Y.S. Treatment of chronic akinetic mutism with atomoxetine: subtraction analysis of brain f-18 fluorodeoxyglu-cose positron emission tomographic images before and after medication: a case report. Clin Neuropharmacol 2010;33(4):209—11. Whyte J., Katz D., Long D. et al. Predictors of outcome in prolonged posttraumatic disorders of consciousness and assessment of medication effects: A multicenter study. Arch Phys Med Rehabil 2005;3:453-62. Leone H., Polsonetti B.W. Amantadine for traumatic brain injury: does it improve cognition and reduce agitation? J Clin Pharm Ther 2005;30:101-4. Meythaler J.M., Brunner R.C., Johnson A., Novack T.A. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. J Head Trauma Rehabil 2002;4:300-13. Hughes S., Colantonio A., Santaguida P.L., Paton T. Amantadine to enhance readiness for rehabilitation following severe traumatic brain injury. Brain Inj 2005;14:1197-206. Sawyer E., Mauro L.S., Ohlinger M.J. Amantadine enhancement of arousal and cognition after traumatic brain injury. Ann Pharmacother 2008;42:247-52. Passler M.A., Riggs R.V. Positive outcomes in traumatic brain injury-vegetative state: patients treated with bromocriptine. Arch Phys Med Rehabil 2001;3:311-5. Krimchansky B.Z., Keren O., Sazbon L., Groswasser Z. Differential time and related appearance of signs, indicating improvement in the state of consciousness in vegetative state traumatic brain injury (VS-TBI) patients after initiation of dopamine treatment. Brain Inj 2004;11:1099-105. Matsuda W., Komatsu Y., Yanaka K., Matsumura A. Levodopa treatment for patients in persistent vegetative or minimally conscious states. Neuropsychol Rehabil 2005;3-4:414-27. Ross E.D., Stewart R.M. Akinetic mutism from hypothalamic damage: successful treatment with dopamine agonists. Neurology 1981;31(11):1435-9. Combarros O., Infante J., Berciano J. Akinetic mutism from frontal lobe damage responding to levodopa. J Neurol 2000;247(7):568-9. Spiegel D.R., Casella D.P., Callender D.M., Dhadwal N. Treatment of akinetic mutism with intramuscular olanzapine: a case series. J Neuropsychiatry Clin Neurosci 2008;20(1):93-5. Лихтерман Л.Б. Неврология черепномозговой травмы. В кн.: Клиническое руководство по черепно-мозговой травме. Т.1. Под ред. А.Н. Коновалова, Л.Б. Лихтермана, А.А. Потапова. М.: АНТИДОР, 2001;231-2. Hendricks H.T., Heeren A.H., Vos P.E. Dysautonomia after severe traumatic brain injury. Eur J Neurol 2010;17(9):1172-7. Baguley I.J, Nott M.T., Slewa-Younan S. et al. Diagnosing dysautonomia after acute traumatic brain injury: evidence for overresponsiveness to afferent stimuli. Arch Phys Med Rehabil 2009;90(4):580-6. Lv L.Q., Hou L.J., Yu M.K. et al. Risk Factors Related to Dysautonomia After Severe Traumatic Brain Injury. J Trauma 2011;71:538-42. Krauss J.K., Wakhloo A.K., Nobbe F. et al. Lesions of dentatothalamic pathways in severe post-traumatic tremor. Neurol Res 1995;17:409-16. Koeda T., Takeshita K. A case report of remarkable improvement of motor disturbances with L-dopa in a patient with post-diffuse axonal injury. Brain Dev 1998;20:124-6. Doder M., Jahanshahi M., Turjanski N. et al. Parkinson's syndrome after closed head injury: a single case report. J Neurol Neurosurg Psychiatry 1999;66:380-5. Matsuda W., Matsumura A., Komatsu Y. et al. Awakenings from persistent vegetative state: report of three cases with parkinsonism and brain stem lesions on MRI. J Neurol Neurosurg Psychiatry 2003;74(11):1571-3. Зайцев О.С., Потапов А.А., Шарова Е.В. и др. Комплексная реабилитация пострадавших с психическими расстройствами вследствие тяжелой черепно-мозговой травмы. Неврол вестн 2009;XLI (4):18—21. Зайцев О.С., Челяпина М.В., Гриненко О.А. и др. Оптимизация психофармакотерапии после тяжелой черепно-мозговой травмы. Доктор Ру 2011;4(63):60—3. Gianutsos G., Chute S., Dunn J.P. Pharmacological changes in dopaminergic systems induced by long-term administration of amantadine. Eur J Pharmacol 1985;110(3):357—61. Allen R.M. Role of amantadine in the management of neuroleptic-induced extrapyramidal syndromes: overview and pharmacology. Clin Neuropharmacol 1983;6(Suppl 1):64—73. Lechin F., van der Dijs B., Pardey- Maldonado B. et al. Effects of amantadine on circulating neurotransmitters in healthy subjects. J Neural Transm 2010;117(3):293—9. Александрова Е.В., Зайцев О.С., Тенедиева В.Д. и др. Катехоламины плазмы крови в процессе восстановления сознания у пострадавших с тяжелой черепно-мозговой травмой. Журн неврол и психиатр 2011;3:58—63.

  2. 2
  3. 3